Changeflow GovPing Healthcare USPTO Patent Grant: Compliance Monitor for Inha...
Routine Notice Added Final

USPTO Patent Grant: Compliance Monitor for Inhaler Usage

Favicon for changeflow.com ChangeBridge: Patent Grants - Medical Devices (A61M)
Published March 24th, 2026
Detected March 25th, 2026
Email

Summary

The USPTO has granted a patent (US12582786B2) for a compliance monitor designed to track patient usage of inhalers. The device features a loosely coupled housing that actuates a dose counter through movement during medication delivery.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582786B2 for a 'Compliance monitor for loosely coupling to an inhaler.' The patent, assigned to Adherium (NZ) Limited, describes a device with a housing that loosely attaches to a medicament delivery device. Movement during dose delivery actuates a dose counter, thereby monitoring patient compliance.

This patent grant is primarily informational and does not impose new regulatory obligations. However, it may be of interest to medical device manufacturers and pharmaceutical companies involved in inhaler technology and patient adherence monitoring. Compliance officers should note this development as it relates to potential future product innovations and intellectual property in the field of drug delivery devices.

Source document (simplified)

← USPTO Patent Grants

Compliance monitor for loosely coupling to an inhaler

Grant US12582786B2 Kind: B2 Mar 24, 2026

Assignee

Adherium (NZ) Limited

Inventors

Garth Campbell Sutherland, Michael James Gormack

Abstract

This invention relates to a compliance monitor for monitoring patient usage of a medicament delivery device, where the medicament delivery device includes a store of medicament and an actuator. The compliance monitor includes a housing adapted to enclose the medicament delivery device, and a dose counter, associated with the housing, for recording the delivery of a dose of medicament to the patient from the medicament delivery device. The arrangement and construction is such that the housing is loosely coupled to the medicament delivery device, whereby the housing is able to move relative to the medicament delivery device during the delivery of the dose of medicament, and it is this movement which actuates the dose counter, either directly or indirectly, in order to record the delivery of the dose of medicament.

CPC Classifications

A61M 15/008 A61M 15/009

Filing Date

2023-05-02

Application No.

18142327

Claims

15

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582786B2

Who this affects

Applies to
Drug manufacturers Medical device makers Patients
Industry sector
3345 Medical Device Manufacturing 3254 Pharmaceutical Manufacturing
Activity scope
Drug Delivery Monitoring Patient Compliance Tracking
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Topics
Medical Devices Patient Monitoring

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Medical Devices (A61M) publishes new changes.

Free. Unsubscribe anytime.